Global synonymous mutagenesis identifies cis-acting RNA elements that regulate HIV-1 splicing and replication by Takata, M. et al.
RESEARCH ARTICLE
Global synonymous mutagenesis identifies
cis-acting RNA elements that regulate HIV-1
splicing and replication
Matthew A. Takata1, Steven J. Soll1,2, Ann Emery3,4,5, Daniel Blanco-Melo1,
Ronald Swanstrom4,5,6, Paul D. Bieniasz1,2*
1 Laboratory of Retrovirology, The Rockefeller University, New York, New York, United States of America,
2 Howard Hughes Medical Institute, The Rockefeller University, New York, New York, United States of
America, 3 Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel
Hill, North Carolina, United States of America, 4 Lineberger Comprehensive Cancer Center, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, 5 Department of
Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United
States of America, 6 Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill,
Chapel Hill, North Carolina, United States of America
* pbieniasz@rockefeller.edu
Abstract
The ~9.5 kilobase HIV-1 genome contains RNA sequences and structures that control many
aspects of viral replication, including transcription, splicing, nuclear export, translation, packag-
ing and reverse transcription. Nonetheless, chemical probing and other approaches suggest
that the HIV-1 genome may contain many more RNA secondary structures of unknown impor-
tance and function. To determine whether there are additional, undiscovered cis-acting RNA
elements in the HIV-1 genome that are important for viral replication, we undertook a global
silent mutagenesis experiment. Sixteen mutant proviruses containing clusters of ~50 to ~200
synonymous mutations covering nearly the entire HIV-1 protein coding sequence were
designed and synthesized. Analyses of these mutant viruses resulted in their division into three
phenotypic groups. Group 1 mutants exhibited near wild-type replication, Group 2 mutants
exhibited replication defects accompanied by perturbed RNA splicing, and Group 3 mutants
had replication defects in the absence of obvious splicing perturbation. The three phenotypes
were caused by mutations that exhibited a clear regional bias in their distribution along the viral
genome, and those that caused replication defects all caused reductions in the level of
unspliced RNA. We characterized in detail the underlying defects for Group 2 mutants. Sec-
ond-site revertants that enabled viral replication could be derived for Group 2 mutants, and
generally contained point mutations that reduced the utilization of proximal splice sites. Map-
ping of the changes responsible for splicing perturbations in Group 2 viruses revealed the pres-
ence of several RNA sequences that apparently suppressed the use of cryptic or canonical
splice sites. Some sequences that affected splicing were diffusely distributed, while others
could be mapped to discrete elements, proximal or distal to the affected splice site(s). Overall,
our data indicate complex negative regulation of HIV-1 splicing by RNA elements in various
regions of the HIV-1 genome that enable balanced splicing and viral replication.
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Author summary
In addition to encoding viral proteins, the HIV-1 genome contains sequence elements
that act at the level of RNA to enable replication. We undertook an experiment to discover
new RNA elements that act in this way by altering nearly the entire coding sequence of
the viral genome so as to change the RNA sequence without changing protein sequences.
This experiment uncovered two classes of defective mutants. One class had profound
defects in RNA splicing, the other had no obvious defects in splicing. Through an analysis
of the splicing-defective mutants, we found several previously RNA sequences in the viral
genome that affected splicing, enabling a nearly complete catalogue of signals that regulate
HIV-1 alternative splicing in infected cells to be derived. Because these newly described
sequences lack sequence motifs that are known to bind to canonical splicing-regulatory
proteins, they may function through novel mechanisms.
Introduction
The HIV-1 genome contains a variety of RNA elements that have important cis-acting func-
tions [1, 2]. Some of these RNA sequences are multi-functional in that they lie in open reading
frames and therefore encode proteins as well as performing functions as RNA that are critical
during viral replication. Known cis-acting RNA elements in the HIV-1 genome that lie within
protein-coding sequences include splice donors, acceptors, and branch points [3], splicing reg-
ulatory elements that enhance or inhibit the use of proximal splice sites [4], the Rev-responsive
element [5, 6], the central polypurine tract and termination sequence [7], the Gag-Pro-Pol
ribosomal frameshift regulatory element [8] and components of the viral genome packaging
signal [9, 10]. It is not known whether the aforementioned represent a complete catalogue of
cis-acting RNA elements, or whether additional RNA-based functionality exists in the HIV-1
genome. That additional RNA sequences function in cis may exist in the HIV-1 genome is sug-
gested by studies employing chemical probing approaches. For example, SHAPE experiments
indicate that individual nucleotides in HIV-1 RNA have widely divergent tendencies to be
base-paired [11–13]. These findings, along with phylogeny-based approaches, strongly suggest
that secondary structures form in HIV-1 RNA that are conserved between strains, and might
therefore serve a function in HIV-1 replication [11, 13]. One example of a recently suggested
function for HIV-1 RNA secondary structure is the regulation of translational rate, whereby
translation is periodically slowed to enable folding of one protein domain of the multidomain
HIV-1 Gag protein before synthesis of the next [11]. However, no evidence for such a phe-
nomenon was found in an analysis of SIVmac [14].
Despite the suggestion that novel RNA secondary structures may be important for HIV-1
replication, targeted mutagenesis of putatively important individual stem loops has not gener-
ally yielded evidence that is strongly supportive of a role for these potential structures in HIV-
1 replication [15]. Conversely, some studies in which portions of the HIV-1 genome were syn-
onymously mutated have suggested a role for RNA (as opposed to protein) sequence or struc-
ture in HIV-1 replication [16, 17]. However, the precise nature of defects induced by
synonymous mutations are unclear, and possibly pleiotropic.
RNA sequence and structure must play a key role in a particular aspect of HIV-1 replica-
tion, namely alternative splicing. Indeed, RNA secondary structure surrounding the major 5’
splice donor affects splicing [18, 19] and SHAPE analysis revealed a novel stem loop that influ-
ences splicing [14, 20]. Nevertheless, the regulatory mechanisms controlling alternative
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splicing are incompletely understood [4, 21]. HIV-1 employs four salient splice donors (D1, D2,
D3, D4) and eight acceptors (A1, A2, A3, A4a,b,c, A5 and A7, S1 Table) to generate a large
number of mRNAs that enable expression of nine viral open reading frames in a temporally
biphasic manner [22]. Additional, ‘cryptic’ splice sites may be used at very low frequency, and
are not required for expression of the viral ORFs (S1 Table). HIV-1 splicing is, by necessity,
inefficient as a substantial fraction of the viral transcripts must remain unspliced so as to pro-
vide viral genomes and Gag-Pol mRNA [21, 23]. Splice-site utilization is regulated by deviation
from consensus splicing signals as well as regulatory elements consisting of exonic and intronic
splicing silencer (ESS and ISS) elements, and exonic splicing enhancer (ESE) elements [4, 21,
23–32] (S1 Table). All HIV-1 splicing involves D1, while splice acceptor sites 5’ to each initiation
codon are used to generate mRNAs encoding the HIV-1 proteins Vif (A1), Vpr (A2), Tat (A3)
Rev (A4a,b,c), Vpu/Env (A4a,b,c and A5) and Nef (A5 and A7) (Fig 1) [3, 4]. In addition, some
Fig 1. Design and analysis of panel of synonymously mutated HIV-1 viruses. (A) Schematic of HIV-1 proviral DNA, indicating open reading frames, splice
sites, and blocks of nucleotides that were synonymously mutated in the 16 proviral plasmids (A-P). (B) Single-cycle infectious titers (measured using MT4
cells) 48h following transfection of 293T cells with each of the WT(HIV-1NHG) and mutant (A-P) proviral plasmids. Valuses are given as mean±sd. (n = 3)
p<0.05, p<0.005 by students t-test, calculated with relative values normalized to WT values in each experiment. (C) Western blot analysis of protein levels
in transfected cells (and virion particles where indicated) at 48h after transfection of 293T cells with each of the WT(HIV-1NHG) and mutant (A-P) proviral
plasmids.
https://doi.org/10.1371/journal.ppat.1006824.g001
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HIV-1 mRNAs include short noncoding exons (SX1 (A1-D2)) and (SX2 (A2-D3)) 5’ to the
expressed open reading frame. The relative frequencies that the various splice sites are used,
which can be measured using next-generation sequencing approaches [20, 33], likely contrib-
utes to ensuring that the optimal levels of viral proteins are synthesized for viral replication.
To identify and catalog regions of the HIV-1 genome that contain critical but unidentified
cis-acting RNA elements that impact splicing and other functions, we employed a global syn-
onymous mutagenesis strategy. Sixteen mutant proviruses, each containing blocks of synony-
mous mutations covering nearly the entire HIV-1 protein coding sequence, were examined.
Despite encoding identical proteins, and despite the fact that all known cis-acting sequences
were maintained in an intact form, some viruses were completely incapable of a spreading
infection. Others mutants displayed apparently normal fitness. Some defective mutants,
termed Group 3 mutants, displayed near normal splicing but were defective in spreading repli-
cation assays. In these cases, second site revertants could not be recovered, and we have
recently demonstrated that these defects are associated with dinucleotide compositional
changes that confer sensitivity to zinc finger antiviral protein (ZAP) [34]. In this study, we
focused on Group 2 mutants that displayed aberrant splicing. We found that replication com-
petence could be recovered by second-site revertant point mutations that were often, but not
always, proximal to splice sites. Sequences responsible for aberrant splicing were sometimes
diffusely distributed, but sometimes could be mapped to discrete elements of 20–120 nucleo-
tides and suggest the existence of novel forms of splicing-suppressive RNA signals. Overall,
this study demonstrates that uncharacterized elements in the HIV-1 genome determine the
fate and splicing of HIV-1 RNA and thus the ability of HIV-1 to replicate.
Results
Design and synthesis of synonymously mutated HIV-1 strains
To determine whether there are important, undiscovered cis-acting elements in the HIV-1
genome, a mutant HIV-1 sequence was designed that contained a maximum number of syn-
onymous mutations in the open reading frames while leaving known RNA elements that are
important for virus replication intact (S1 Table). Mutations were designed so as to maximize
the probability of disrupting base pairing in which a given nucleotide might participate. Thus,
where multiple synonymous mutation possibilities were available, transversion mutations
(purine to pyrimidine or vice versa) were preferred over transition mutations. To avoid the
creation of new splice acceptors and donors, no new AG or GU dinucleotides were introduced.
Moreover, sequences encoding overlapping open reading frames were not altered, and all
known RNA elements that control HIV-1 splicing, gene expression and reverse transcription
(S1 Table) remained intact in the mutant viral genome.
This designed HIV-1 sequence contained 1,976 synonymous mutations (S2 Table, S1 Data,
S2 Data) and was divided into 150–500 nucleotide blocks, that were synthesized separately.
Each synthetic mutated fragment was introduced into a replication competent HIV-1 proviral
plasmid (HIV-1NHG) [35] that carried GFP in place of the nonessential gene Nef (S2 Table, S1
Data, S2 Data.). Thus, sixteen different mutated proviral plasmids, designated A through P,
with each carrying a mean of ~125 synonymous mutations were generated (Fig 1A).
Protein expression and replication properties of synonymously mutated
HIV-1 mutants
Each of the synyonymously mutated HIV-1NHG proviral plasmids was transfected into 293T
cells and the infectious virion yield was determined in a single-cycle infection assay in MT4
RNA elements that regulate HIV-1 splicing and replication
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cells (Fig 1B). Many of the mutants yielded WT, or close to WT, levels of infectious virions in
this transfection/titration assay format. However, mutants A, B, I, and J yielded between 5-fold
and 1000-fold fewer infectious virions (Fig 1B). Western blot analysis of the transfected 293T
cells and extracellular virions showed that mutants A and B expressed additional Gag protein
species of unexpected sizes, and mutant B displayed a particle release defect, possibly a conse-
quence of the expression of the aberrant Gag protein (Fig 1C). Mutants I and J displayed
reduced Gag, Pol, Env and Vif protein, and slightly elevated GFP levels. Mutant J also grossly
overexpressed the Vpr protein (Fig 1C).
We next examined whether each of the mutants could replicate in MT4 and CEM T-cell
lines (Fig 2 and S1 Fig). Seven of the mutants (D, E, F, G, H, N and P) replicated with WT, or
close to WT, kinetics while eight other mutants, (A, B, I, J, K, L, M, and O) were replication
defective, or highly impaired, in both cell lines (Fig 2 and S1 Fig.). Mutant C was somewhat
impaired in MT4 cells, but replicated with close to WT kinetics in CEM cells. Thus, an appar-
ent discrepancy was evident in the ability of some of the mutants to generate infectious virions
in 293T cells, versus their ability to generate a spreading infection in T-cell lines.
Assays for splicing perturbations in replication-defective HIV-1 mutants
The viral mutants were designed to avoid altering RNA sequences in the HIV-1 genome that
are known to be important for replication, including those that participate in or regulate splic-
ing (S1 Table). Nevertheless, the aberrant pattern of viral protein expression in two of the syn-
onymously mutated viruses (I, J), and the appearance of novel Gag-related protein species in
two others (A, B), suggested that HIV-1 splicing might have been perturbed in at least some of
the mutant viruses (Fig 1C). Therefore, we next used two approaches to determine whether
the mutations affected splicing in each of the mutant viruses. We used a recently described
Primer ID-based deep sequencing approach [20] to globally quantify the relative utilization of
the various splice donors and acceptors in the mutant viruses (Fig 3A–3E). We also used a
fluorescent primer-based PCR-PAGE assay to more conveniently, albeit less quantitatively,
track the generation of the major mRNA species in the canonical spliced 1.8 kb class of HIV-1
mRNAs (Fig 3F). These two assays yielded results that were in good agreement (see below). Of
the canonical splice acceptors in the central portion of the genome (A1, A2, A3 A4a,b,c, and
A5, Fig 3A), the WT HIV-1NHG most frequently spliced to A5, with lower levels of splicing to
A1, A2, A3, A4a,b,c (Fig 3A, 3C and 3F).
Activation of cryptic splice sites in mutants A and B (Group 2a)
A splicing defect was observed for mutants A and B, which contained synonymous changes
toward the 5’ end of the HIV-1 genome, within gag. For each of these mutants, the relative lev-
els of canonical splice site utilization were only marginally perturbed, but the Primer ID-based
sequencing assay revealed that cryptic splice sites near the 5’ end of the genome were activated
(Fig 3B, 3C and 3D). These mutants were designated Group 2a. For mutant A, a cryptic splice
acceptor at position 955 (A955) and a donor at position 1169 (D1169) were activated, neither of
which was used at a measurable level in WT HIV-1NHG (Fig 3A and 3B). While A955 was used
rarely (~1% of 1.8 kb mRNAs) in mutant A, ~14% of the 1.8 kb mRNAs were spliced using
D1169. (Fig 3B). Splicing events involving D1169 were selective with respect to which of the
downstream acceptors were used: A3, A4, or A5, were used as acceptors for D1169 but A1 or
A2 were not. MaxEnt scoring, which employs an in silico analysis tool that predicts the intrin-
sic splicing efficiency of splice acceptors and donor sequences [36], indicated that our muta-
genesis increased the score of the cryptic acceptor A955 from -9.88 to 1.75, suggesting that it
became a stronger splice acceptor (S3 Table). Thus, the minimal activation of A955 (used in
RNA elements that regulate HIV-1 splicing and replication
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Fig 2. Spreading replication properties of mutant viruses. (A-P) MT4 cells were infected with the indicated virus (harvested from the supernatant of
293T cells transfected with each of the WT(HIV-1NHG) or mutant (A-P) proviral plasmids at an MOI of 0.002. Aliquots of infected cells were
RNA elements that regulate HIV-1 splicing and replication
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1% of spliced reads) in mutant A, could possibly be explained by a direct effect of the muta-
tions. However, the predominant defect in mutant A was the activation of D1169, which lies
outside the mutated region (Fig 3A) and whose MaxEnt score was not altered. Thus, activation
of D1169 could not be due to increased intrinsic efficiency of this cryptic donor, but rather due
to some other mechanism acting via RNA sequences distal to D1169.
For mutant B, the major perturbation was activation of a cryptic splice acceptor at position
1321 (A1321, Fig 3A and 3B). This splicing event, involving ~12% of mRNAs in the 1.8 kb class,
appeared to enable a cascade of further alternative splicing events, 50% of which subsequently
involved cryptic splice donor activation at either D1509 or D1725, outside the B mutant region
(Fig 3B). However, the most obvious outcome of the aberrant splicing event was the generation
of a truncated ~40 kD Gag protein (Fig 2B). This protein would be the expected translation
product of an mRNA in which a D1- A1321 splice, and no further splicing, had occurred. Spe-
cifically, translation initiation at the second Met codon in the gag gene would generate a trun-
cated ~40 kD Gag protein lacking MA, that likely accounts for the aberrant band on the cell-
associated Gag western blot as well as the reduced particle yield from cells transfected with the
B mutant proviral plasmid (Fig 1C).
For mutant B, the activation of A1321 may be due to a direct effect of the mutations increas-
ing its MaxEnt score from -2.94 to 7.03, again suggesting it became a stronger splice acceptor
(S3 Table). The other cryptic sites activated, D1509 and D1725, are both outside of the mutated
region in mutant B, and their use was likely secondary to activation of A1321.
Overuse of canonical splice acceptor sites in mutants I, J and K (Group 2b)
Viruses containing mutations in the central portion of the genome, specifically mutants I, J
and K, exhibited a different type of splicing defect, and were designated Group 2b. Specifically,
mutants I, J and K exhibited increased direct splicing to canonical splice acceptors, A1, A2 and
A3 respectively, at the expense of direct splicing to downstream (3’) acceptors (Fig 3C). In the
case of mutant I, the primary defect (increased use of A1) was accompanied by increased use
of the proximal downstream splice donor (D2) as well as a downstream acceptor–donor pair
(A2 and D3) and thus the abundant inclusion of short exons (SX) 1 and 2 (SX1 = [A1-D2] and
SX2 = [A2-D3]) into spliced viral mRNAs (Fig 3D). Some elevation of the use of upstream
cryptic splice sites in mutant I (D3569, D3969, D4641 and A4834) also generated low levels of novel
transcripts (Fig 3F). For mutant J, overuse of A2 (which is positioned 3’ to SX1) was accompa-
nied by overuse of proximal downstream splice donor D3 and thus overrepresentation of SX2
= [A2-D3] into spliced viral mRNAs (Fig 3D). Additionally, some utilization of cryptic splice
donors (D5052, D5434, and D5478) generated low levels of novel transcripts (Fig 3F). For mutant
K, overuse of A3 (which is positioned 3’ to SX1 and SX2) did not result in the more frequent
inclusion of these short exons (Fig 3D). Overall therefore, it appeared that one consequence of
the overuse of a given splice acceptor (A1 or A2), was a resultant overuse of the proximal
downstream splice donor (D2 or D3), consistent with an ‘exon definition’ model of splicing
control.
This overuse of canonical splice acceptors in I, J and K resulted in aberrant representation
of particular viral mRNAs. Among the 1.8 kb class of mRNAs, for WT HIV-1, Nef2 was the
dominant mRNA species in both splicing assays (Fig 3E and 3F). Conversely, in mutant I,
Nef5 was the dominant mRNA, while in mutant J, Nef4, Tat3 and Vpr1 were overrepresented
(Fig 3E and 3F). These changes were likely responsible for the overexpression of GFP (in the
withdrawn each day, fixed in 4% PFA and the proportion of infected cells determined by FACS analysis of GFP expression. a Representative replication
curve for WT(HIV-1NHG) is plotted in each chart as grey symbols and line, while each mutant is plotted using red symbols and lines.
https://doi.org/10.1371/journal.ppat.1006824.g002
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Fig 3. Analysis of HIV-1 splicing in WT and synonymously mutated HIV-1. (A) Schematic representation of
segments of HIV-1 proviral DNA, focused on mutants exhibiting perturbed splicing. Canonical splice sites (black) and
RNA elements that regulate HIV-1 splicing and replication
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nef position) and/or Vpr in these mutants (Fig 1C). For mutant K, Tat1 mRNA was over-rep-
resented (Fig 3E and 3F), but the overall levels of protein expression were not greatly affected
in transfected cells.
Viruses with blocks of synonymous mutations with three different
phenotypes that map to distinct regions of the HIV-1 genome
For other replication defective mutants (L, M, and O) that we termed Group 3, the relative
uses of splice sites appeared normal, despite obvious replication defects (Fig 2, Fig 3B–3E).
These viruses appeared to express a normal complement of viral proteins in transfected cells
(Fig 1C). Overall, therefore, analyses of viral replication and RNA splicing led to the classifica-
tion of the synonymously mutated viruses into three groups (Fig 4A): Group 1 mutants exhib-
ited near WT fitness, Group 2 mutants exhibited replication defects accompanied by
perturbed RNA splicing, while Group 3 mutants had profound replication defects in the
absence of obvious splicing perturbation. The three phenotypes were caused by mutations that
exhibited a clear regional bias with respect to their distribution along the viral genome (Fig
4A). Specifically, Group 1 viruses carried mutations throughout the pro (D) and pol (E to H)
genes or in the 3’ portion of the env gene (N, P), and replicated indistinguishably from HIV-
1NHG. Conversely, Group 2 viruses with obvious splicing defects carried mutations in two dis-
tinct genomic regions: Group 2a viruses (A, B) carried mutations toward the 5’ end of the
genome, within gag, while Group 2b viruses (I, J, K) carried mutations or in the central por-
tions of the genome, within the accessory genes (Fig 4A). Group 3 viruses (L, M, O) that were
defective but exhibited near-normal splicing carried mutations in the env gene (Fig 4A).
Single-cycle replication assays suggest that reduced levels of unspliced viral
RNA underlie replication defects in synonymously mutated HIV-1
We next explored the discrepancy in the abilities of certain mutant viruses to yield infectious
virions after transfection of 293T cells, but were unable to spread in MT4 cells (Fig 2). We
examined this discrepancy by carrying out experiments that analyzed a single cycle of replica-
tion in MT4 cells. Specifically, we infected cells with each of the mutant viruses at an M.O.I. of
1 and quantified infectious virion release (Fig 4B) as well as levels of full length unspliced viral
mRNA, during the first cycle of infection (Fig 4C). These experiments revealed significant defi-
ciencies in infectious virion yield from infected cells for mutants A, B, K, L and M, that were
not evident or less evident when virions were generated after transfection of 293T cells with a
plasmid containing full length viral DNA (Fig 4B, Fig 1B). Moreover, these deficiencies, and
the inability of each mutant virus to support a spreading infection, correlated with reduced lev-
els of unspliced HIV-1 RNA in infected cells (Fig 4A and 4C). These observations suggest that
the underlying defect in each of the replication defective mutants is a deficit in maintaining
the level of unspliced RNA. This deficiency likely result from excessive or aberrant splicing for
cryptic splice sites (red) are indicated, as are blocks of nucleotides that were synonymously mutated in the viruses
exhibiting perturbed splicing. (B-E) Nextgen sequencing analysis of HIV-1 splicing, heatmaps indicate relative
proportion of sequencing reads that indicate splicing at the sites indicated at the bottom of the heatmaps (B, C), or
inclusion of the short exons (SX1 and/or SX2) indicated at the bottom of the heatmap (D). For panel (C) only direct
splicing to the indicated acceptor sites is indicated in the heatmap. Alternatively, the relative abundance of the various
1.8 kb mRNA species is indicated (E). (F) Fluorescent primer PCR analysis of HIV-1 splicing. 293T cells were
transfected with the indicated proviruses, RNA extracted and cDNA synthesized. A sense PCR primer situated 5’ to the
major splice donor, along with an antisense primer positioned either 3’ to A7 or 3’ to D4 (labelled with IRD800) were
used to amplify cDNAs derived from the 1.8 kb (top) or 4 kb (bottom) classes of spliced HIV-1 mRNAs respectively.
PCR products were subjected to PAGE and a LI-COR Odyssey scanner was used to detect fluorescent signals directly
from the gels.
https://doi.org/10.1371/journal.ppat.1006824.g003
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Group 2 mutants. Conversely we have recently shown that at least one of the Group 3 viruses
was sensitized to the antiviral protein, ZAP, through the cumulative effect of incidentally
included CG dinucleotides during the synonymous mutagenesis [34]. It therefore appears
likely that the deficit in unspliced RNA can be overcome, for some mutants, through the over-
expression that results from transient viral DNA transfection in 293T cells. However, each of
the mutants with reduced levels of unspliced RNA in single cycle-infected cells was profoundly
defective in a spreading replication assay (Fig 4A).
Fig 4. Phenotypes of synonymously mutated HIV-1 viruses. (A) Summary of the properties of HIV-1 viruses carrying blocks of nucleotides that were
synonymously mutated (A-P). The frequency of splice site utilization was assessed in transfected 293T cells (Fig 3), Single-cycle replication assays were used
to assess unspliced RNA levels and infectious virus yield (see panels B and C below). Replication competence was determined using spreading replication
assays (Fig 2 and S1 Fig). (B) Infectious virion yield measured in the supernatant of MT4 cells, infected with each of the mutant viruses at an MOI of 1.0, and
harvested 2 days post infection. Values are the mean ±sd n = 3 or n = 2 experiments, p<0.05, p<0.005 by students t-test calculated with relative values
compared to wildtype virus ( Values were below the limit of quantitation). (C) Levels of unspliced HIV-1 genomes in RNA extracted from MT4 cells,
infected with each of the mutant viruses at an MOI of 1.0, and harvested 2 days post infection, mean ±sd n = 3 or n = 2 experiments, p<0.05 by students t-
test compared to wildtype virus. ( Values were below the limit of quantitation).
https://doi.org/10.1371/journal.ppat.1006824.g004
RNA elements that regulate HIV-1 splicing and replication
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Mapping elements responsible for splicing perturbations in Group 2
viruses
To determine the sequence elements responsible for the perturbations in splicing in Group 2a
and Group 2b viruses we took two approaches. First, we attempted to derive second-site rever-
tant viruses through passage of each viral mutant in MT4 cells. Second, we applied a mapping
approach, in which each block of mutations in mutants A, B, I, J and K was divided into
roughly equally sized component segments (S2 Table), and the splicing properties of each sec-
ondary mutant re-examined. Through an iterative process, sometimes combining mapping
and second-site revertant derivation, we could determine the nature of the defects in each
Group 2 mutant and map the responsible cis-acting sequences.
Native HIV-1 RNA sequence confers suppression of cryptic splice sites that
are activated in Group 2a mutant viruses
For mutants A and B in which cryptic splice sites within the gag gene were activated by the
silent mutations, we first attempted to derive revertant viruses by passage in MT4 cells. For
both mutants A and B, passage quickly yielded viruses that replicated more rapidly than the
parental mutants viruses (Fig 5A and 5B, S2 Fig). In the case of mutant A, passage in MT4 cells
yielded a revertant virus that replicated well, albeit with delayed kinetics relative to WT HIV-
1NHG and contained two nucleotide substitutions relative to the A mutant parent. One of these
mutations (C819T) was responsible for the revertant replication phenotype (Fig 5A). The
C819T mutation was synonymous, and while it occurred at a position that differs from the
WT in mutant A, the reversion was not to the WT sequence (WT = G819, mutant A = C819,
revertant = T819). Thus, if position G819 in the WT virus was involved in a hypothetical RNA
secondary structure that was perturbed or induced in mutant A (C819), then the C to T substi-
tution in the revertant would not be expected to affect the perturbation of that secondary struc-
ture. The C819T revertant largely corrected the predominant splicing defects in mutant A,
reducing the use of the cryptic splice acceptor (A955) from ~ 1% to ~0.1% and the cryptic splice
donor (D1169) from ~14% to<1% (Fig 5C). Since the reversion mutation C819 was distal to
the cryptic splice sites (~140 and ~350 nucleotides 5’ to A955 and D1169, respectively, Fig 5D)
the mechanism by which it exerts its effect was unclear. Notably, the revertant mutation
occurred within a few nucleotides of the reported secondary structure that includes the HIV-1
packaging sequence, and D1 (which is at position 743). Thus, it may be that the revertant
mutation acts by modulating the secondary structure surrounding D1, rather than on the cryp-
tic A955 and D1169 that were activated in mutant A.
For mutant B, passage in MT4 or CEM cells yielded two different replicating revertant
viruses each of which contained a single nucleotide substitution relative to the B mutant
(G1326A in MT4 cells and T1311C in CEM cells) (Fig 5B, S2 Fig) Both revertant mutations
were synonymous, at positions that differed in WT and mutant B viruses. Both mutations
were proximal to the cryptic splice acceptor (A1321) that was activated by the B mutations (Fig
5E).
Analysis of the G1326A revertant in the NGS splicing assay indicated reduced use of the
cryptic acceptor A1321, D1509, and D1725 (from 12%, 2.9%, and 3.9% to<1% respectively Fig
5C). Given the proximity of the reversion mutations to the silenced cryptic splice site, it is
likely that these mutations act directly to reduce splicing factor binding, and thereby reduce
the use of the cryptic A1321. However, only the T1311C mutation had a marginal effect on the
predicted strength of A1321, reducing the MaxEnt score from7.03 to 6.09 (S3 Table), while
G1326A had no effect on the MaxEnt score, yet this mutation abolished the use of A1321 as an
acceptor. Mutations in mutant B may have created or revealed a splicing factor binding site
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that was otherwise limiting for the use of the cryptic A1321 in a manner that was reversed by
the G1326A and T1311C revertant mutations.
To map mutations in A and B that were responsible for activating cryptic splice sites D1169
and A1321 respectively, we generated a set of mutant viruses (AA, AB, AC, AD, AE and BA, BB,
Fig 5. Activation of cryptic splice sites by synonymous mutations in Gag. (A, B) MT4 cells were infected with the indicated virus (harvested from the
supernatant of 293T cells transfected proviral plasmids representing each of the WT(HIV-1NHG), mutant (A, B and revertants (A C819T, A1130G and B
T1311C, G1326A) thereof) at an MOI of 0.002. Aliquots of infected cells were withdrawn each day and the proportion of infected cells determined by
FACS analysis of GFP expression. (C) Next gen sequencing analysis of HIV-1 splicing. The heatmap indicates relative proportion of sequencing reads that
used the cryptic splice sites for WT(HIV-1NHG), mutant (A, B and revertants thereof). (D,E) Schematic representation of the mutant blocks of nucleotides
in HIV-1 mutants A (D) and B (F), indicating positions of mutant derivatives (AA, AB, BA, BB) etc, and the positions of cryptic splice sites and revertant
mutant sites. Blocks colored blue are those that conferred overt splicing perturbations when mutated. (F) Fluorescent primer PCR analysis of HIV-1
splicing in mutant A. A sense PCR primer situated 5’ to the cryptic donor D1169, was used along with an antisense primer positioned 3’ to A7 (labelled
with IRD800) was used to amplify cDNAs derived from the 1.8 kb class of spliced HIV-1 mRNAs respectively. (G) Fluorescent primer PCR analysis of
HIV-1 splicing in mutant B. A sense PCR primer situated 5’ to D1, was used along with an antisense primer positioned 3’ to the mutant B block (labelled
with IRD800) was used to amplify cDNAs derived HIV-1 mRNAs. For panels (F) and (G) PCR products were subjected to PAGE and a LI-COR Odyssey
scanner was used to detect fluorescent signals directly from the gels.
https://doi.org/10.1371/journal.ppat.1006824.g005
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BC, BD, BE) that contained subsets of the synonymous mutations present in mutants A and B
(Fig 5D and 5E). We also designed a fluorescent primer-based PCR-PAGE assay in which a
PCR primers were positioned to conveniently and specifically monitor the major aberrant
splicing event in mutants A and B which, as expected, yielded PCR product consistent with
splicing at the respective cryptic splice sites (D1169 and A1321, respectively) (Fig 5F and 5G).
Surprisingly, none of the secondary mutants containing subsets of the A and B mutations reca-
pitulated the effects of the A and B mutations (Fig 5F and 5G). Thus, the activation of the cryp-
tic splice sites by the Group 2a mutants A and B was the result of multiple synonymous
changes in those mutant viruses. Additionally, the apparent inability of MaxEnt scoring to
consistently predict cryptic site utilization in the context of these mutants indicated that splic-
ing defects could not be due solely to direct enhancing effects of mutations on specific cryptic
sites.
Multiple features of HIV-1 RNA suppress splicing at A1 and A2
For mutant I, which exhibits overuse of A1 and A2, as well as the corresponding donors (D2
and D3) positioned immediately 3’ to A1 and A2, (Fig 6A) we failed to obtain revertant replica-
tion competent viruses, even after extended passage. Therefore, we divided the I segment into
5’ and 3’ halves and generated two derivative mutant viruses (IA and IB) each of which had
approximately half the of the synonymous mutations that were present in I (Fig 6A). Both IA
and IB mutants also exhibited splicing defects that were primarily manifested as overuse of A1,
but these defects were less complete, in that some degree of direct splicing to downstream
acceptors (e.g. A5) was present in both IA and IB (Fig 6B). Notably, IA exhibited oversplicing
at A1 and (unlike the parent mutant I) the cryptic splice donor D2b [37]. Conversely IB exhib-
ited direct oversplicing at both A1 and, to some degree, to A2 but not D2b (Fig 6B).
Both IA and IB could replicate with delayed kinetics compared to HIV-1NHG, and extended
passage of IA and IB yielded point mutation revertants that could replicate with kinetics close
to those of HIV-1NHG (Fig 6C and 6D, S2 Fig). In the case of IA, a T4904A mutation occurred
in the A1 polypyrimidine tract (Fig 6A and 6C). This caused a profound reduction of splicing
at A1 and likely as a consequence, reduction of the inclusion of SX1 (A1-D2) in spliced RNAs
(Fig 6B). Use of the cryptic D2b site was also abolished in the IA(T4904A) revertant. In fact,
other than underuse of A1 and reduced inclusion of SX1, the IA(T4904A) revertant had a near
normal splicing pattern Thus, activation of canonical and cryptic downstream splice donors in
mutant IA appeared to be secondary to activation of A1.
For mutant IB, the situation was more complex; a revertant (G4912A) was recovered after
passage (S2 Fig), precisely at the A1 acceptor that abolished the use of A1, and consequently
the inclusion of SX1 into spliced mRNA (Fig 6A, 6B and 6D). However, significant overuse of
A2, and consequent inclusion of SX2 (A2-D3) remained evident in the IB(G4912A) revertant
(Fig 6B). Indeed, overuse of A2 was more prominent in the IB(G4912A) revertant than in IB,
perhaps because of the functional removal of A1 (Fig 6B). It was therefore apparent that native
sequences within IA result in suppression of splicing at A1, while sequences within IB cause
suppression of splicing at both A1 and A2.
To map elements within IA and IB that control splicing at A1 and A2, we used the fluores-
cent PCR-based assay to analyze the pattern of splicing for viruses containing subsets of the IA
and IB mutations. For IA, analysis of viruses containing smaller component mutant elements
(IC and ID, Fig 6A) revealed that aberrant splicing was conferred only by the ID element (Fig
6E). Thereafter, when ID was subdivided into ID1 and ID2, it was evident that the controlling
element resided primarily within ID2 (Fig 6E). Thus, this analysis revealed a 48 nucleotide
sequence that appeared to suppress splicing at A1. Notably, a novel ESS/ESE element, termed
RNA elements that regulate HIV-1 splicing and replication
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006824 January 29, 2018 13 / 26
Fig 6. Activation of canonical splice acceptor sites (A1 and A2) by synonymous mutations in mutant I. (A) Schematic representation of the mutant
blocks of nucleotides in HIV-1 mutant I, indicating positions of mutant derivatives (IA, IB, IC. . ..etc), and the positions of splice sites and revertant mutant
sites (blue arrows). Blocks colored blue are those that conferred overt splicing perturbations when mutated. (B) Next gen sequencing analysis of HIV-1
splicing in transfected 293T cells. The heatmap indicates relative proportion of sequencing reads that indicate direct splicing to the indicated acceptors or
inclusion of the short exons (SX1 and/or SX2) as indicated at the bottom of the heatmap for WT(HIV-1NHG), mutants I, IA, IB and revertants thereof. (C,
D) MT4 cells were infected with the indicated virus (harvested from the supernatant of 293T cells transfected proviral plasmids representing WT(HIV-
1NHG), mutant (I, IA, IB and revertants thereof) at an MOI of 0.002. Aliquots of infected cells were withdrawn each day and the proportion of infected cells
determined by FACS analysis of GFP expression. (E, F) Fluorescent primer PCR analysis of HIV-1 splicing. 293T cells were transfected with the indicated
WT and mutant proviruses, RNA extracted and cDNA synthesized. A sense PCR primer situated 5’ to the major splice donor, was used along with an
antisense primer positioned 3’ to A7 (labelled with IRD800) to amplify cDNAs derived from the 1.8 kb class of spliced HIV-1 mRNAs. PCR products were
subjected to PAGE and a LI-COR Odyssey scanner was used to detect fluorescent signals directly from the gels. Salient mRNA species determined by direct
sequencing of extracted gel bands, or inferred from Nextgen sequencing assays are indicated.
https://doi.org/10.1371/journal.ppat.1006824.g006
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ESS2b/ESE2b was recently identified that nearly precisely coincides with ID2 [32], indicating
that our approach has the potential to identify novel splicing regulatory signals.
Notably, the unmutated IA segment contained short runs of three G’s (G3) that have been
reported to constitute hnRNP binding sites which suppress the activation of the cryptic splice
donor D2b [37]. The mutations in IA disrupted two of these G3 runs (Fig 6A) and D2b was
used in ~17% of IA spliced reads. The revertant mutation IA(4904) was able to inhibit activa-
tion of D2b from 17% to 2% (Fig 6B), suggesting that the activation of D2b is predominately a
secondary effect of A1 overutilization. Nevertheless, one of the G3 motifs coincides with the
ID2 segment and therefore disruption of the G3 motifs may also contribute to the activation of
the cryptic D2b site.
For IB the situation was more complex, as mutations in this segment control splicing at
both A1 and A2. Nevertheless, subdivision of the IB mutations into components IE and IF (Fig
6A), revealed that the majority the effect of IB mutations were conferred by mutations in IF.
However, IF did not exhibit as prominent a degree of perturbation as IB (Fig 6E). Even though
the splicing of mutant IE appeared normal, mutations in IE made some contribution to the
defects present in IB (Fig 6E). Subdivision of IF into IF1 and IF2 yielded viruses with a normal
pattern of splicing (Fig 6F). Thus, it was evident that multiple sequences acting together in IB,
distributed over IE, but primarily concentrated in IF1 and IF2, regulate splicing at A1 and A2
and their overall contributions could not be mapped through this approach to a single small
candidate regulatory element.
For mutant J, which exhibited overuse of A2 and D3 we also failed to obtain revertant repli-
cation competent viruses, even after extended passage. Therefore, we divided the J segment
into 5’ and 3’ halves and generated two derivative mutant viruses (JA and JB, Fig 7A).
Although there was some degree of splicing perturbation in JB (Fig 7B), this perturbation was
modest compared to J and JA. Moreover, JB was only marginally delayed in spreading replica-
tion assays compared to HIV-1NHG. (Fig 7C). Therefore, we did not attempt to select JB rever-
tants. Conversely, JA recapitulated the splicing perturbation observed in J, and was replication
defective (Fig 7B and 7D). Extended passage of mutant JA yielded a revertant mutation
(G5463A) that enabled replication (Fig 7D, S2 Fig). Notably, the reversion mutation was pre-
cisely at, and inactivated donor D3 (Fig 7A), but also abolished splicing to A2 (Fig 7B). The
enhancing effect of D3 on A2 splicing has previously been demonstrated [38]. Interestingly,
even though D3 appeared to be required for splicing at A2 only a fraction of RNAs that are
spliced to A2 are also spliced at D3. It was notable that the JB mutants as well as the JA
(G5463A) revertant exhibited some oversplicing to A1 (and therefore elevated inclusion of
SX1) even though the J mutant sequences were distal (~440 to 890 nucleotides) to A1 (Fig 7A
and 7B).
To map elements within JA that control splicing, we used the fluorescent PCR-based assay
for the 1.8 kb HIV-1 mRNAs to analyze viruses containing subsets of the JA mutations. We
divided the JA mutant segment into 5’ and 3’ halves in two derivative mutant viruses (JC and
JD, Fig 7A) which both exhibited some degree of perturbed splicing (Fig 7E). Further subdivi-
sion of JC into JC1, JC2 and JC3 clearly suggested that the 20 nucleotide JC2 segment con-
tained an element whose mutation was primarily responsible for the perturbed splicing in JC
(Fig 7E), but further division of 20 nucleotide JC2 yielded two mutant segments (JC2A and
JC2B) both of which cause perturbed splicing to nearly the same degree as the J, JA, JC and
JC2 mutant segments from which they were derived (Fig 7F). Division of the JD segment into
JD1 and JD2 clearly revealed another element within the 46 nucleotide JD1 segment, that
when mutated yielded a oversplicing pattern similar to that of the J mutant virus (Fig 7E).
Thus, multiple mutations within the JA fragment, contained within the segments JC2 and JD1
were capable of causing oversplicing defects similar to those observed in the J mutant.
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A discrete RNA sequence regulates HIV-1 splicing at A3.
For mutant K (Fig 8A), which exhibits overuse of A3 (Fig 8B), it proved straightforward to
recover a revertant mutant virus through passage that corrected the splicing defect and
Fig 7. Activation of canonical splice acceptor site A2 by synonymous mutations in mutant J. (A) Schematic representation of the mutant blocks of
nucleotides in HIV-1 mutant J, indicating positions of mutant derivatives (JA, JB, JC. . ..etc), and the positions of splice sites and revertant mutant sites (blue
arrows). Blocks colored blue are those that conferred overt splicing perturbations when mutated. (B) Next gen sequencing analysis of HIV-1 splicing in
transfected 293T cells. The heatmap indicates relative proportion of sequencing reads that indicate direct splicing to the acceptors or inclusion of the short
exons (SX1 and/or SX2) indicated at the bottom of the heatmap for WT(HIV-1NHG), mutants J, JA, JB and revertants thereof. (C, D) MT4 cells were infected
with the indicated virus (harvested from the supernatant of 293T cells transfected proviral plasmids representing each of the WT(HIV-1NHG), mutant or
revertant viruses at an MOI of 0.002. Aliquots of infected cells were withdrawn each day and the proportion of infected cells determined by FACS analysis of
GFP expression. (E, F) Fluorescent primer PCR analysis of HIV-1 splicing. 293T cells were transfected with the indicated WT (HIV-1NHG) and mutant
proviruses, RNA extracted and cDNA synthesized. A sense PCR primer situated 5’ to the major splice donor, was used along with an antisense primer
positioned 3’ to A7 (labeled with IRD800) to amplify cDNAs derived from the 1.8 kb class of spliced HIV-1 mRNAs. PCR products were subjected to PAGE
and a LI-COR Odyssey scanner was used to detect fluorescent signals directly from the gels. Salient mRNA species determined by direct sequencing of
extracted gel bands, or inferred from Nextgen sequencing assays are indicated.
https://doi.org/10.1371/journal.ppat.1006824.g007
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replicated well (Fig 8B and 8C, S2 Fig). This revertant contained two mutations, one of which
(C5774T) was sufficient to restore replication to near WT kinetics (Fig 8C). This functional
reversion mutation was 3 nucleotides from A3. Notably the K(C5774T) revertant not only cor-
rected overuse of A3 but exhibited a splicing pattern that was nearly indistinguishable from
that of HIV-1NHG (Fig 8B). This was surprising because previous studies have reported that
CAG and TAG are used at a similar efficiency as 3’ splice acceptors in the context of HeLa cell
Fig 8. Activation of canonical splice acceptor site A3 by synonymous mutations in mutant K. (A) Schematic representation of the mutant blocks of
nucleotides in HIV-1 mutant K, indicating positions of mutant derivatives (KA, KB, KC. . ..etc), and the positions of splice sites and revertant mutant sites
(blue arrows). Blocks colored blue are those that conferred overt splicing perturbations when mutated. (B) Next gen sequencing analysis of HIV-1 splicing in
transfected 293T cells. The heatmap indicates relative proportion of sequencing reads that indicate direct splicing to the acceptors or inclusion of the short
exons (SX1 and/or SX2) indicated at the bottom of the heatmap for WT(HIV-1NHG), mutant K and the C5774T revertant. (C) MT4 cells were infected with
the indicated virus (harvested from the supernatant of 293T cells transfected proviral plasmids representing each of the WT(HIV-1NHG), mutant or revertant
viruses at an MOI of 0.002. Aliquots of infected cells were withdrawn each day and the proportion of infected cells determined by FACS analysis of GFP
expression. (D, E, F) Fluorescent primer PCR analysis of HIV-1 splicing. 293T cells were transfected with the indicated WT (HIV-1NHG) and mutant
proviruses, RNA extracted and cDNA synthesized. A sense PCR primer situated 5’ to the major splice donor, was used along with an antisense primer
positioned 3’ to A7 (labeled with IRD800) to amplify cDNAs derived from the 1.8 kb class of spliced HIV-1 mRNAs. PCR products were subjected to PAGE
and a LI-COR Odyssey scanner was used to detect fluorescent signals directly from the gels. Salient mRNA species determined by direct sequencing of
extracted gel bands, or inferred from Nextgen sequencing assays are indicated.
https://doi.org/10.1371/journal.ppat.1006824.g008
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nuclear extracts [39]. The remarkable diminution of splicing in the K(C5774T) reversion
mutant suggests that in the context of A3, the TAG is far less well utilized than CAG. Further,
the A3 MaxEnt score of is increased from 9.76 to 10.05 in the context of the K(C5774T) re-
version mutant, predicting that A3 is a stronger acceptor in K(C5774T). However, experi-
mentally the reverse is the case, demonstrating the limitation of both in silico and in vitro
analyses to predict splicing phenotypes in the context of a full-length HIV-1 construct in a liv-
ing cell.
To map sequences within the K mutant that were responsible for causing oversplicing, we
divided the K mutant segment into two halves (KA and KB, Fig 8A) and analyzed the pattern
of 1.8 kb mRNAs using the fluorescent primer PCR assay. This analysis revealed that muta-
tions responsible for A3 overuse resided in KA (Fig 8D). Then, further subdivision of KA (into
KC and KD) revealed that KD contained the controlling element(s) (Fig 8D). Finally, subdivi-
sion of KD (into KD1 and KD2) showed that KD2 contained RNA sequences whose mutation
caused oversplicing (Fig 8E), but further subdivision of KD2 (into KD2A and KD2B) showed
that mutations in both of these KD2 components contributed its effect (Fig 8F). Thus, a
23-nucleotide element (KD2) positioned >100nt from A3 contained an RNA element whose
sequence influences splicing at A3.
Discussion
Through a global synonymous mutagenesis experiment we found that extensive portions of
the HIV-1 genome could be synonymously mutated without major effects on viral replication
(Group 1 mutants). In particular, synonymous mutations throughout the majority of the pol
gene had a minimal or no effect on viral fitness, such that their effect was not measurable in
our assays. Given the extent of the mutations that were introduced, and the improbability that
most RNA secondary structures would be preserved in our mutants, it seems unlikely that
undiscovered specific RNA secondary structures essential for replication exist in portions of
the viral genome covered by Group 1 mutants. Even among mutants that were replication
defective, Group 2 mutants could be restored to replication competence through single nucle-
otide reversion mutations that suppressed the utilization of cryptic or canonical splice sites,
whose use was enabled or elevated in the global mutagenesis experiment. Again, this argues
against the notion that undiscovered, specific RNA structures that are essential for replication
are prevalent in Group 2 mutants, with the exception of those that regulate splicing.
An important caveat to this conclusion is that replication was measured in permissive cell
lines in the absence of competition. It is possible, even likely, that mutants or revertants with
WT or near WT replication dynamics, have modest fitness deficits that would be evident in a
more stringent environment or a competitive replication assay. For example, some of the
HIV-1 accessory genes are important in vivo, but non-essential in vitro, therefore defects in
their expression would be expected to have minimal effects on replication in our assays. Thus,
while we can reasonably conclude that RNA secondary structures in Group 1 and Group 2
revertant mutants are non-essential for replication per se, it is nevertheless possible that RNA
structures play an accessory role in regulating or fine-tuning the levels or fates of mRNAs
encoding certain accessory proteins.
Nevertheless, synonymous mutations in some portions of the HIV-1 genome caused pro-
found, near-lethal defects in these highly permissive T-cell lines (Group 2 and Group 3
mutants). These mutations therefore perturbed essential, non-coding features of the HIV-1
nucleotide sequence. One noncoding feature of the HIV-1 genome that appeared important
for replication that was uncovered by our Group 2a mutants was suppression of cryptic splice
sites near the 5’ end of the RNA genome. For these mutants, the magnitude of the deviation
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from WT sequence appeared important for cryptic site activation. Simply subdividing the
mutant sequence blocks into two mutant blocks approximately equal lengths (e.g. mutants
AA, AB and BA, BB) reverted the mutant splicing phenotype. This finding suggests that activa-
tion of the existing cryptic splice sites resulted from multiple perturbations to the gag nucleo-
tide sequence and that changes in predicted splice site strength were not sufficient to explain
their activation. Moreover, in the case of mutant A, a single nucleotide revertant mutation that
occurred distal to the activated cryptic splice sites corrected the splicing defect without affect-
ing their MaxEnt scores. These findings might be best explained by the existence of multiple
elements in the gag gene (secondary structures or protein binding sites) that act redundantly
to suppress cryptic splice site utilization. The fact that the revertant mutation for mutant A
occurred at a position proximal to an existing RNA structure that includes D1 [40, 41], may
suggest a role for an extended secondary structure involving the 5’ leader and the gag gene in
suppressing the utilization of potential cryptic splice sites in gag. The potential for the 5’ leader
to form alternative structures that could affect splicing appears to be finely tuned [42], and
therefore could possibly be perturbed by distal mutations in gag. Clearly, further work will be
required to understand how the WT noncoding RNA sequence is selected to avoid utilization
of cryptic splice sites.
A detailed analysis of Group 2b mutants, that targeted the central portion of the genome,
revealed several elements whose perturbation resulted in dramatic overuse of the canonical
splice acceptors A1, A2, and A3. These mutant elements that resulted in oversplicing could be
mapped to sequences of various lengths. Such sequences constitute candidate individual or
clustered ESS elements. When combined with existing knowledge of splicing regulation, at A1,
A2 and A3 [4, 21, 23–32], these and previous findings suggest a highly complex regulatory net-
work of functional inputs that govern alternative splicing of the HIV-1 genome, as depicted in
(Fig 9).
Fig 9. Summary of splicing control in HIV-1. (A) Schematic representation of the central portion of the HIV-1 genome with the positions of
canonical splice sites indicated. Previously identified splicing control elements are indicated with grey lines. Sequences identified in this study
whose mutation enhanced splicing are indicated with red lines and the splice acceptors on which they act are indicated with red arrows. (B) The
sequences of the identified elements that affect splicing (upper line = WT sequence, lower line = oversplicing mutant sequence) are shown.
https://doi.org/10.1371/journal.ppat.1006824.g009
RNA elements that regulate HIV-1 splicing and replication
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006824 January 29, 2018 19 / 26
The phenotypes of some mutant and revertant viruses (i.e. viruses with perturbed splicing
whose replication was recovered by mutations at splice sites) is consistent with the notion that
exon definition (i.e. coordinated recognition of a 5’ splice acceptor and a 3’ splice donor by the
splicing machinery [43]) plays a central role in the regulation of HIV-1 alternative splicing. For
example, the mutant (IA) that exhibits elevated use of A1 and the downstream donor D2 (as well
as the cryptic donor D2b) while the revertant (IA(T4904A)) occurred at A1 and reduced utiliza-
tion of D2, and D2b as well as A1. Similarly, in IB, that exhibits elevated use of both A1 and A2,
both downstream donors D3 and D2 are also overused. In this case, the revertant mutation (IB
(G4912A)) at A1 caused abolition of splicing at both A1 and D2 while splicing at A2 and D3
remain elevated. Consistent with the notion that splicing at A1 and D2 are coordinated, previous
work has shown that the efficiency with which D2 is recognized can affect the frequency of splic-
ing at A1 [44]. Similar communication occurs between A2 and D3. Indeed, for a mutant (JA) that
exhibited profound oversplicing at A2 and D3, a reversion mutation (JA(G54653A)) that inacti-
vated D3 also caused abolition of splicing at A2. Because not all splices at A2 lead to splicing at
D3, this observation suggests that recognition of D3 by the splicing machinery is required for
splicing at A2 even when D3 is not utilized, as has previously been suggested [23, 38]. Overall
therefore, a major determinant of the use of a given acceptor or donor in the HIV-1 genome was
the use of a downstream donor or upstream acceptor, respectively.
Our data is also consistent with the notion that splice acceptor sites compete with each
other, with ‘cascading’ effects based on exon definition. For example, the mutant (JA) under-
utilizes A1 and over-utilizes A2. Its revertant (JA(G54653A)) that abolishes splicing at both D3
and A2, causes over-utilization of A1. In a reciprocal example of A1-A2 competition, abolition
of A1 utilization in the revertant IB(G4912A), was accompanied by increased splicing at A2.
Acceptor competition was also evident in the context of the mutant K, which exhibited over-
splicing at A3 at the expense of splicing at A1, A2, A4b and A5. In this case, the reversion
mutation at A3 in K(C5774T) led to restoration of WT splicing frequency at all other sites in
the central portion of the HIV-1 genome.
Overall therefore, a key regulator of the use of a particular splice site is the presence and uti-
lization of other splice sites, through coordinated recognition of acceptor and donor sites,
along with competition between acceptor sites. Thus, disruption of the splicing regulatory sig-
nals whose existence is indicated herein can have complex effects on overall splicing, through
the propagation of their effects from one splice site to another. Clearly the overall effect of
these perturbations is best appreciated in the nextgen sequencing assay with all splice sites rep-
resented in a viral construct.
That being the case, the RNA sequence elements that we have identified as apparent regula-
tors of splice acceptor utilization (Fig 9) could work directly or indirectly. Specifically, they
could act to directly inhibit access of the splicing machinery to the affected splice acceptors or
indirectly through splice donors, inhibiting acceptor utilization by inhibiting exon definition.
It is also possible that our mutations affect the ability of splice sites to effectively communicate
with each other in the context of exon definition. Existing splicing regulatory sequences have
been reported to exert their effect through binding of hnRNP or SR proteins, or through the
formation of RNA secondary structures [45]. The sequences that we have identified are of
varying sizes; some elements that had major effects on splicing appear sufficiently small (e.g.
JC2 and KD2) to constitute specific protein binding sites. However, these elements did not
appear to be enriched in canonical hnRNP binding motifs, as might be expected for splicing
silencers [45]. Some of the effects on splicing that we found in our mutants, particularly within
the I and J fragments, appeared complex and not easily mapped to small discrete elements.
Perhaps these effects are the result of combinatorial inputs from multiple binding sites or sec-
ondary structures that could act to occlude splice sites, or spatially separate 3’ donors from 5’
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acceptors thereby inhibiting exon definition. Further work will be required to determine pre-
cisely how these elements inhibit HIV-1 splicing.
Perturbation of balanced splicing did not always lead to abolition of HIV-1 replication. For
example, the mutants JB and JA(5463A) had perturbed splicing (overuse of A1 for JA, and abo-
lition of SX2 utilization for JB) but their replication was only slightly delayed compared to
WT. Similarly the IB(G4912A) revertant virus had near WT replication but completely lacked
splicing to A1 and therefore abolished inclusion of SX1. These perturbations would be
expected to lead to underexpression or overexpression of Vif and Vpr, neither of which are
essential for replication in the particular cell type used in our experiments. Thus, the require-
ment for a particular balance of HIV-1 mRNAs could be highly context dependent. In our
experiments, replication defects that resulted from over-splicing were likely the result of deple-
tion of the pool of unspliced RNA, thus leading to lower levels of synthesis of Gag, Pro, Pol,
and other viral proteins, and lower levels of viral genomes for packaging. Thus, a key role of
splicing inhibitory signals in the HIV-1 genome is to maintain the unspliced RNA pool, as well
as adequate levels of necessary viral proteins.
Overall, our global synonymous mutagenesis experiment has revealed several RNA ele-
ments whose native sequence is important for HIV-1 replication. In particular, we have identi-
fied several RNA elements in the HIV-1 genome whose native sequence appears to be
important for suppression of canonical splice sites, regulation of alternative splicing and main-
tenance of unspliced transcript levels. Additionally, our analysis revealed that some as yet
unidentified property of RNA sequences in the gag gene suppresses utilization of cryptic splice
sites. Understanding how RNA sequence affects splicing in the context of HIV-1 may give
insights into the general mechanisms by which alternative splicing is regulated and how splic-
ing regulation evolves, as well as opportunities to intervene therapeutically in HIV-1 infection.
Material and methods
Cell lines, viruses and infections
293T cells (ATCC) were grown in DMEM with 10% fetal bovine serum (Sigma). MT4 cells
(NIH AIDS Reagent Repository) were cultured in RPMI supplemented with 10% fetal bovine
serum. HIV-1NHG and mutant derivatives containing a reporter GFP in place of nef were pro-
duced by transfection of 293T cells with the proviral plasmid using PEI. Virus titers were
determined by FACS analysis of target MT4 cells. Dextran sulfate was added to inhibit reinfec-
tion at 18 hours post infection and the number of infected cells determined by FACS analysis
of GFP expression 2 days post infection.
For spreading replication infections, 2x105 MT4 cells in 2 mL of media were infected at an
MOI of 0.002. Aliquots of infected cells were withdrawn each day, fixed in 4% PFA and the
proportion of infected cells determined by FACS analysis of GFP expression. For single cycle
infections, cells were infected with HIV-1NHG or mutants thereof, at an MOI of 1.0, and har-
vested 2 days post infection for western blot and qPCR analysis. Serial passage of mutant
viruses was started by infecting a culture of 5x105 MT4 cells at an MOI of 0.002 and time
points were fixed in 4% PFA. Upon infection of the entire culture, 200 μL of cell free superna-
tant was filtered and used to inoculate a new culture of 5x105 MT4 cells. After the final passage,
the cells were collected and the DNA was extracted (Qiagen Tissue Mini Kit), then the mutated
region was sequenced to determine the revertant mutation that had occurred.
Construction of mutant proviral plasmids
The mutated regions of the HIV-1 genome were synthesized (Genewiz) and cloned into HIV-
1NHG using restriction digest sites that were proximal to the mutated regions (S2 Table).
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Division of the original mutants blocks into two new derivative mutants was achieved using
overlap extension PCR based approaches with mutant and WT templates. Revertant mutations
acquired through passage of the virus were reconstituted into the original mutant provirus
from which they arose through site directed mutagenesis and overlap extension PCR.
PCR quantification of unspliced HIV-1 RNA
RNA was extracted from infected cells using Trizol and reverse transcribed using the Super-
Script III reverse transcriptase (ThermoFisher). The resulting cDNA was used as a temple for
quantitative real-time PCR using the ABI Fast RT-PCR system along with the Fast Start Taq-
Man Probe master mix. Unspliced viral RNA was detected using a forward primer: 5’-GGAC
TTGAAAGCGAAAGGGA-3’, a reverse primer: 5’-TCTCTCTCCTTCTAGCCTCCG-3’ and a
TaqMan probe 5’-GGGCGGCGACTGGTGAGT-3’ targeting the major splice donor D1.
Serial tenfold dilutions of known copy numbers of HIV-1NHG plasmid was used to generate a
standard curve.
Antibodies and western blotting
Cells were normalized for cell number, lysed in SDS sample buffer, separated by electrophore-
sis on NuPage 4–12% Bis-Tris gels (Novex) and blotted onto nitrocellulose membranes (GE
Healthcare). Blots were probed with an HIV-1 anti-capsid antibody (183-H12-5C) obtained
from the NIH AIDS reagent repository, a GFP antibody (G1546, Sigma), and HIV-1 anti-Env
gp120 antibody (12-6205-1, American Research Products).
Analysis of HIV-1 splicing with fluorescent primer PCR
RNA from 293T cells transfected with mutant provirus was extracted using the Nucleospin
RNA extraction kit (Machery Nagel). RNA was reverse transcribed using SuperScript III
reverse transcriptase (ThermoFisher) with gene specific primers for either fully spliced
(8483R: 5’-CCGCAGATCGTCCCAGATAAG-3’ and partially spliced (6223R: 5’-CAAGTGC
TGATATTTCTCCTTCAC -3’) mRNA classes. The cDNA templates were then used in a 10μL
PCR reaction with fluorescent reverse primers specific to the splice class (labelled at their 5’
ends with IRD800) and a forward primer position 5’ to the major splice donor (499F: 5’ -CTG
AGCCTGGGAGCTCTCTGGC-3’) and run for 25 cycles with an annealing temperature of
54˚C. Alternatively, to determine use of the activated cryptic splice site in mutant A, a forward
primer, positioned 5’ to the mutations (763F 5’- TGACTAGCGGAGGCTAGAAGGAGA-
GAG -3’) and the fluorescent reverse primer for the fully spliced class (8483R) were used in a
PCR reaction with the cDNA templates. To determine use of the activated cryptic splice site in
mutant B, the forward primer 499F and a fluorescent reverse primer 5’ to the mutations in B
(1557R 5’- GATAGGTGGATTATGTGTCATCC -3’) were used in a PCR reaction with the
cDNA template. Then, 10μL of 2x TBE-Urea sample buffer was added to the PCR reaction
which was then run on a 6% TBE-Urea gel for 90 minutes at 180V (Novex). A LI-COR Odys-
sey scanner was used to detect fluorescent signals directly from the gels.
Analysis of HIV-1 splicing using Primer ID-based deep sequencing
Determination of splice site utilization using the Primer ID-based deep sequencing assay was
done substantially as described with minor modifications [20]. Briefly, RNA was extracted
from cells transfected with HIV-1NHG or mutants thereof using the RNeasy Plus minikit (Qia-
gen). Primers used for cDNA synthesis were GTGACTGGAGTTCAGACGTGTGCTCTTCC
GATCTNNNNNNNNNNNNNNCAGTTCGGGATTGGGAGGTGGGTTGC for 1.8 kb
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spliced transcripts and GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNNN
NNNNNNNGCTACTATTGCTATTTGTATAGGTTGCATTACATG for 4 kb spliced tran-
scripts. Indexed primers were obtained from Integrated DNA Technologies Custom Oligos.
Total cell RNA (8 μg) was subjected to cDNA synthesis, purification and cleanup and an initial
PCR amplification. An aliquot of the product from this first PCR was used as the template
for the second PCR to add the Illumina adapter and bar codes to allow multiplexing in the
Illumina sequencing reaction. PCR products were visualized on a 2% agarose gel and then
cleaned. Libraries were mixed/multiplexed and sequenced using the 300-base paired-end read
for the Illumina Miseq platform. Reads were sorted using the Illumina bcl2fastq pipeline
(v.1.8.4) to separate the multiplexed samples. Subsequent Data analysis and splicing quantifica-
tion were done using the previously described in-house pipeline [20] written in Ruby and
adapted to accommodate the mutated sequences. This program uses the combined sequence
information from the paired-end reads to identify splice site usage and transcript type. Reads
are condensed by Primer ID to prevent skewing in the PCR steps. Cryptic alternative donor and
acceptor splice sites were identified using a program that compares data reads to a reference
sequence and identifies the base where a splice discontinuity occurs and the base it splices to.
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